A Trial of Oseltamivir in High-Risk Patients Presenting to the Emergency Department With Influenza
Status:
Terminated
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
A multi-centre, randomized, placebo controlled, trial. Participants will be patients either
≥65 years or with one or more high risk conditions presenting to one of four academic
emergency departments in Edmonton or Calgary with influenza-like illness. The investigators
will test for influenza using a point-of-care rapid test and if positive for influenza
participants will be randomized to oseltamivir or placebo and followed prospectively. The
primary outcome will be hospitalization.